BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 19362149)

  • 1. Molecular imaging of cell death.
    De Saint-Hubert M; Prinsen K; Mortelmans L; Verbruggen A; Mottaghy FM
    Methods; 2009 Jun; 48(2):178-87. PubMed ID: 19362149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Necrosis avidity of (99m)Tc(CO)3-labeled pamoic acid derivatives: synthesis and preliminary biological evaluation in animal models of necrosis.
    Fonge H; Chitneni SK; Lixin J; Vunckx K; Prinsen K; Nuyts J; Mortelmans L; Bormans G; Ni Y; Verbruggen A
    Bioconjug Chem; 2007; 18(6):1924-34. PubMed ID: 17929883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A simplified method for preparation of 99mTc-annexin V and its biologic evaluation for in vivo imaging of apoptosis after photodynamic therapy.
    Subbarayan M; Häfeli UO; Feyes DK; Unnithan J; Emancipator SN; Mukhtar H
    J Nucl Med; 2003 Apr; 44(4):650-6. PubMed ID: 12679412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiolabeling and preliminary biological evaluation of a (99m)Tc(CO)(3) labeled 3,3'-(benzylidene)-bis-(1H-indole-2-carbohydrazide) derivative as a potential SPECT tracer for in vivo visualization of necrosis.
    Prinsen K; Jin L; Vunckx K; De Saint-Hubert M; Zhou L; Cleynhens J; Nuyts J; Bormans G; Ni Y; Verbruggen A
    Bioorg Med Chem Lett; 2011 Jan; 21(1):502-5. PubMed ID: 21075631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo imaging of apoptosis in patients with acute stroke: correlation with blood-brain barrier permeability.
    Lorberboym M; Blankenberg FG; Sadeh M; Lampl Y
    Brain Res; 2006 Aug; 1103(1):13-9. PubMed ID: 16806116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 99mTc-labeled C2A domain of synaptotagmin I as a target-specific molecular probe for noninvasive imaging of acute myocardial infarction.
    Zhao M; Zhu X; Ji S; Zhou J; Ozker KS; Fang W; Molthen RC; Hellman RS
    J Nucl Med; 2006 Aug; 47(8):1367-74. PubMed ID: 16883018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of 99mTc-glucarate as a breast cancer imaging agent in a xenograft animal model.
    Gambini JP; Cabral P; Alonso O; Savio E; Figueroa SD; Zhang X; Ma L; Deutscher SL; Quinn TP
    Nucl Med Biol; 2011 Feb; 38(2):255-60. PubMed ID: 21315281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-invasive in vivo imaging of myocardial apoptosis and necrosis.
    Flotats A; Carrió I
    Eur J Nucl Med Mol Imaging; 2003 Apr; 30(4):615-30. PubMed ID: 12638039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the C2A domain of synaptotagmin-I and annexin-V as probes for detecting cell death.
    Alam IS; Neves AA; Witney TH; Boren J; Brindle KM
    Bioconjug Chem; 2010 May; 21(5):884-91. PubMed ID: 20402461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Molecular imaging of apoptosis and necrosis -- basic principles of cell biology and use in oncology].
    Böhm I; Träber F; Block W; Schild H
    Rofo; 2006 Mar; 178(3):263-71. PubMed ID: 16508832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Annexin A5: an imaging biomarker of cardiovascular risk.
    Laufer EM; Reutelingsperger CP; Narula J; Hofstra L
    Basic Res Cardiol; 2008 Mar; 103(2):95-104. PubMed ID: 18324365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Translational imaging: imaging of apoptosis.
    Strauss HW; Blankenberg F; Vanderheyden JL; Tait J
    Handb Exp Pharmacol; 2008; (185 Pt 2):259-75. PubMed ID: 18626606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Molecular imaging of apoptosis in cardiovascular diseases].
    Böhm I; Heverhagen JT; Behe M; Greschus S; Willinek W; Lohmaier S; Wilhelm K; Block W; Träber F; Schild H
    Rofo; 2007 Aug; 179(8):780-9. PubMed ID: 17599287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imaging apoptosis for detecting plaque instability: rendering death a brighter facade.
    Corsten MF; Reutelingsperger CP; Hofstra L
    Curr Opin Biotechnol; 2007 Feb; 18(1):83-9. PubMed ID: 17275277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell death: current difficulties in discriminating apoptosis from necrosis in the context of pathological processes in vivo.
    Columbano A
    J Cell Biochem; 1995 Jun; 58(2):181-90. PubMed ID: 7673326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiolabeling of annexin A5 with (99m)Tc: comparison of HYNIC-Tc vs. iminothiolane-Tc-tricarbonyl conjugates.
    Biechlin ML; Bonmartin A; Gilly FN; Fraysse M; du Moulinet d'Hardemare A
    Nucl Med Biol; 2008 Aug; 35(6):679-87. PubMed ID: 18678353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of labeled Annexin A5 in imaging of programmed cell death. From animal to clinical imaging.
    Kietselaer BL; Hofstra L; Dumont EA; Reutelingsperger CP; Heidendal GA
    Q J Nucl Med; 2003 Dec; 47(4):349-61. PubMed ID: 14973424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiolabeling of HYNIC-annexin V with technetium-99m for in vivo imaging of apoptosis.
    Blankenberg FG; Vanderheyden JL; Strauss HW; Tait JF
    Nat Protoc; 2006; 1(1):108-10. PubMed ID: 17406220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preliminary in vivo evaluation of a novel 99mTc-labeled HYNIC-cys-annexin A5 as an apoptosis imaging agent.
    Fonge H; de Saint Hubert M; Vunckx K; Rattat D; Nuyts J; Bormans G; Ni Y; Reutelingsperger C; Verbruggen A
    Bioorg Med Chem Lett; 2008 Jul; 18(13):3794-8. PubMed ID: 18524580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apoptosis-detecting radioligands: current state of the art and future perspectives.
    Lahorte CM; Vanderheyden JL; Steinmetz N; Van de Wiele C; Dierckx RA; Slegers G
    Eur J Nucl Med Mol Imaging; 2004 Jun; 31(6):887-919. PubMed ID: 15138718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.